[ad_1]
FILE PHOTO: This illustration, taken on April 10, 2020, shows small vials labeled with a “COVID-19 Vaccine” label and a medical syringe. REUTERS / Dado Ruvic / Illustration
WASHINGTON – Johnson & Johnson said Monday it had temporarily stopped its Covid-19 vaccine test because one of its participants had fallen ill.
“We have temporarily stopped additional dosing in all of our COVID-19 vaccine candidate clinical trials, including the ENSEMBLE Phase 3 trial, due to unexplained illness in a study participant,” the company said in a statement.
The hiatus means the online enrollment system has been closed for the 60,000-patient clinical trial while the independent committee on patient safety is convened.
JPV
RELATED STORY:
Sanofi, GSK Launches Trial for COVID-19 Protein-Based Vaccine
For more news on the new coronavirus, click here.
What you need to know about the coronavirus.
For more information on COVID-19, call the DOH hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare leaders and still accepts cash donations to be deposited into the Banco de Oro (BDO) checking account # 007960018860 or donate through PayMaya using this link .
Read next
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer and more than 70 other titles, share up to 5 gadgets, listen to the news, download from 4am and share articles on social media. Call 896 6000.
For comments, complaints or inquiries, please contact us.
[ad_2]
